What are my options after PARP inhibitor and immunotherapy?

Experts Dr. Timothy Yap and Dr. Cathy Dumbrava discuss the treatments and clinical trials available for those whose cancer has returned after the use of a PARP inhibitor and immunotherapy.
Dr. Timothy Yap is a Medical Oncologist and Physician-Scientist based at the University of Texas MD Anderson Cancer Center. He is an Associate Professor in the Department for Investigational Cancer Therapeutics (Phase I Program), and the Department of Thoracic/Head and Neck Medical Oncology.
Dr. Cathy Dumbrava is an Assistant Professor in the Department of Investigational Cancer Therapeutics at the University of Texas MD Anderson Cancer Center specializing in early phase clinical trials.